Medicare Enrolled
Dr. Jack Freimann, M.D.
Optician · Whittier, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Freimann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Freimann?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Freimann
Dr. Jack Freimann is an optician specialist in Whittier, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Freimann performed 3,073 Medicare services across 623 unique beneficiaries.
Between the years covered by Open Payments, Dr. Freimann received a total of $23,941 from 104 pharmaceutical and/or device companies across 1113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Freimann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 28% volume in CA
$23,941 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,073
Medicare services
Top 28% in CA for optician
623
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~162 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (ondansetron/Zofran) | 1,000 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
770 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
329 | $105 | $271 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
273 | $8 | $13 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
84 | $8 | $14 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
75 | $122 | $307 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
74 | $66 | $150 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
73 | $82 | $140 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $56 | $193 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
50 | $26 | $66 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
47 | $26 | $61 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
45 | $91 | $213 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
41 | $10 | $21 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
38 | $57 | $198 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
30 | $60 | $151 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
29 | $1 | $2 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $144 | $363 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $99 | $260 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $119 | $351 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.0% high complexity
58.5% medium
36.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,941
Total received (2018-2024)
Avg $3,420/year across 7 years
Top 8% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
104
Companies
1,113
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,083 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$858 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,302
2023
$4,769
2022
$4,119
2021
$3,456
2020
$2,846
2019
$2,979
2018
$2,470
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$370
Merck Sharp & Dohme LLC
$231
Incyte Corporation
$200
PFIZER INC.
$199
Celgene Corporation
$183
Takeda Pharmaceuticals U.S.A., Inc.
$179
Gilead Sciences, Inc.
$162
AstraZeneca Pharmaceuticals LP
$127
Daiichi Sankyo Inc.
$123
Janssen Biotech, Inc.
$114
Exelixis Inc.
$104
ABBVIE INC.
$101
Astellas Pharma US Inc
$100
EMD Serono, Inc.
$73
Regeneron Healthcare Solutions, Inc.
$65
TAIHO ONCOLOGY, INC.
$61
Deciphera Pharmaceuticals Inc.
$60
GlaxoSmithKline, LLC.
$60
GENZYME CORPORATION
$58
BeiGene USA, Inc.
$55
ARRAY BIOPHARMA INC
$52
Aveo Pharmaceuticals, Inc.
$51
Eisai Inc.
$51
Tempus AI, Inc
$46
Novocure Inc.
$35
JAZZ PHARMACEUTICALS INC.
$35
Ipsen Biopharmaceuticals, Inc
$33
Genmab U.S., Inc.
$32
PUMA BIOTECHNOLOGY, INC.
$30
E.R. Squibb & Sons, L.L.C.
$30
Blueprint Medicines Corporation
$28
Lilly USA, LLC
$27
Rigel Pharmaceuticals, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$23
Coherus Biosciences Inc.
$22
SERVIER PHARMACEUTICALS LLC
$22
PharmaEssentia USA Corporation
$22
RECORDATI_RARE_DISEASES_INC.
$21
Kyowa Kirin, Inc.
$21
Mirati Therapeutics, Inc.
$20
SOBI, INC
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
PROGENICS PHARMACEUTICALS, INC.
$15
Top 3 companies account for 24.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,335
Celgene Corporation
$1,425
PFIZER INC.
$1,195
Amgen Inc.
$1,143
Incyte Corporation
$1,051
AstraZeneca Pharmaceuticals LP
$963
Astellas Pharma US Inc
$865
GENZYME CORPORATION
$737
Janssen Biotech, Inc.
$715
E.R. Squibb & Sons, L.L.C.
$688
Takeda Pharmaceuticals U.S.A., Inc.
$673
Merck Sharp & Dohme Corporation
$670
Exelixis Inc.
$648
Merck Sharp & Dohme LLC
$635
Pharmacyclics LLC, An AbbVie Company
$557
GlaxoSmithKline, LLC.
$544
Gilead Sciences, Inc.
$502
Boehringer Ingelheim Pharmaceuticals, Inc.
$375
Karyopharm Therapeutics Inc.
$358
Daiichi Sankyo Inc.
$352
Genentech USA, Inc.
$344
Seagen Inc.
$336
Lilly USA, LLC
$321
Ipsen Biopharmaceuticals, Inc
$299
Eisai Inc.
$294
Bayer HealthCare Pharmaceuticals Inc.
$290
EMD Serono, Inc.
$287
EISAI INC.
$258
Clovis Oncology, Inc.
$243
Regeneron Healthcare Solutions, Inc.
$220
AbbVie, Inc.
$205
Pharmacyclics LLC, an AbbVie Company
$200
Kite Pharma, Inc.
$177
ARRAY BIOPHARMA INC
$163
Puma Biotechnology, Inc.
$159
Taiho Oncology, Inc.
$150
Seattle Genetics, Inc.
$143
ABBVIE INC.
$140
Deciphera Pharmaceuticals Inc.
$139
BeiGene USA, Inc.
$135
Rigel Pharmaceuticals, Inc.
$132
Teva Pharmaceuticals USA, Inc.
$132
PUMA BIOTECHNOLOGY, INC.
$111
Alexion Pharmaceuticals, Inc.
$106
TAIHO ONCOLOGY, INC.
$101
Bayer Healthcare Pharmaceuticals Inc.
$100
EUSA Pharma (US) LLC
$96
Kyowa Kirin, Inc.
$94
Dova Pharmaceuticals
$84
Blueprint Medicines Corporation
$84
Mirati Therapeutics, Inc.
$83
Verastem, Inc.
$82
Foundation Medicine, Inc.
$75
Sobi, Inc
$74
Genmab U.S., Inc.
$74
Aveo Pharmaceuticals, Inc.
$66
Novocure Inc.
$66
Epizyme, Inc.,
$63
JAZZ PHARMACEUTICALS INC.
$59
SOBI, INC
$58
ImmunoGen, Inc.
$53
MEDIVATION FIELD SOLUTIONS LLC
$53
Secura Bio, Inc.
$52
TESARO, Inc.
$49
Stemline Therapeutics Inc.
$48
Tempus AI, Inc
$46
PharmaEssentia USA Corporation
$46
SERVIER PHARMACEUTICALS LLC
$45
MorphoSys, US Inc.
$44
ADC Therapeutics America, Inc.
$44
Emmaus Medical, Inc.
$42
AbbVie Inc.
$41
Servier Pharmaceuticals LLC
$41
Agios Pharmaceuticals, Inc.
$39
AVEO Pharmaceuticals, Inc.
$37
Cumberland Pharmaceuticals, Inc.
$34
Janssen Scientific Affairs, LLC
$29
Pharmacosmos Therapeutics Inc.
$28
Adaptive Biotechnologies Corporation
$27
Aurobindo Pharma USA, Inc.
$24
Myovant Sciences Inc.
$24
Jazz Pharmaceuticals Inc.
$23
Lexicon Pharmaceuticals, Inc.
$22
G1 Therapeutics, Inc.
$22
Shire North American Group Inc
$22
Coherus Biosciences Inc.
$22
Immunomedics, Inc.
$21
Array BioPharma Inc.
$21
Verity Pharmaceuticals Inc.
$21
INSYS Therapeutics Inc
$21
RECORDATI_RARE_DISEASES_INC.
$21
Octapharma USA, Inc.
$21
GE HEALTHCARE
$20
CSL Behring
$20
Spectrum Pharmaceuticals Inc.
$16
Sun Pharmaceutical Industries Inc.
$16
Helsinn Therapeutics (U.S.), Inc.
$16
TOLMAR Pharmaceuticals, Inc.
$16
Acceleron Pharma, Inc.
$15
PROGENICS PHARMACEUTICALS, INC.
$15
Partner Therapeutics, Inc.
$14
Myriad Genetic Laboratories, Inc.
$14
Sirtex Medical Inc
$9
Organon LLC
$8
Top 3 companies account for 20.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Avastin · BALVERSA · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Elahere · Endari · Enhertu · Epkinly · Erleada · FARYDAK · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAMIFANT · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idelvion · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · POTELIGEO · PROMACTA · PYLARIFY · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · SYLVANT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · YONSA · ZEJULA · ZEPZELCA · clonoSEQ · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for optician in CA.
Geographic Context
Opticians within 10 mi
1,751
Per 100K population
17.8
County median income
$87,760
Nearest hospital
PIH HEALTH HOSPITAL-WHITTIER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Freimann is a mixed practice specialist, with above-average Medicare volume (top 28% in CA), with low-engagement industry engagement in the top 8% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Freimann experienced with anti-nausea injection (ondansetron/zofran)?
Based on Medicare claims data, Dr. Freimann performed 1,000 anti-nausea injection (ondansetron/zofran) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Freimann receive payments from pharmaceutical companies?
Yes. Dr. Freimann received a total of $23,941 from 104 companies across 1,113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Freimann's costs compare to other opticians in Whittier?
Dr. Freimann's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Freimann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Whittier
Browse opticians in Whittier ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology